News from the healthcare data industry
TAMPA, Fla., Dec. 9, 2021 /PRNewswire/ — M2GEN, a bioinformatics company accelerating discoveries in oncology research through superior data and analytics, today announced it is partnering with Microsoft to advance and scale its unique data-driven solutions for the discovery, research and development of new oncology therapies. The collaboration brings together Microsoft’s healthcare-focused…
By Joyoti Goswami December 10, 2021 Photo by Westend61/Getty Images In the COVID-19 era, health systems recognize that existing data infrastructure is inadequate. Here are three things large datasets need to be useful. Wearables and smartphone apps have grown in popularity in recent years. More patients are self-monitoring their health…
PROVIDENCE, R.I. [Brown University] — A $25 million gift from accomplished life sciences entrepreneur and investor Pablo Legorreta and his wife, Almudena, will advance a plan to transform Brown University’s recently launched cancer center into a world-class cancer center located in Rhode Island. The gift will rename the Cancer Center at Brown…
CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced six abstracts accepted for poster sessions at the 2021 San Antonio Breast Cancer Symposium (SABCS) taking place December 7 – 10. The presented findings highlight the unique insights that Tempus’ data and smart diagnostics generate to advance breast…
DENVER & PALO ALTO, Calif.–(BUSINESS WIRE)–Babylon Holdings Limited (NYSE: BBLN) (“Babylon”) — a world leading company re-engineering how people engage with their health at every step of the care continuum — and Palantir Technologies Inc. (NYSE: PLTR) (“Palantir”), a leading builder of operating systems for the modern enterprise — today…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx to be used as a companion diagnostic for two groups of current and future FDA-approved therapeutics in melanoma, which includes BRAF inhibitor monotherapies targeting BRAFV600E and BRAF/MEK inhibitor combination…
December 07, 2021 07:00 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Radicle Science, a transformative healthtech B-corp validating natural products for the first time, announces initial findings from the Radicle ACES (Advancing CBD Education and Science) study–history’s largest longitudinal real world evidence (RWE) study of nearly 3,000 participants to determine effectiveness…
Liberating the genetics, laboratory and pharmacy data that sits deep within healthcare subsystems, while protecting patient information and navigating the global regulatory landscape, is no easy task but would greatly help in the treatment of diseases. By SUSAN DALLABRIDA AND CRAIG GRAVINA / Dec 6, 2021 at 5:56 PM For years, health…
MENLO PARK, Calif. and SINGAPORE, Dec. 06, 2021 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the appointment of IQVIA Biotech, a leading global provider of advanced analytics, technology solutions, and clinical research services to…
DARMSTADT, Germany, and DENVER, Dec. 7, 2021 /PRNewswire/ — Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Palantir Technologies Inc. (NYSE:PLTR), a leading builder of operating systems for the modern enterprise, today announced a new partnership to deliver a secure collaborative data analytics platform for the semiconductor industry. The Athinia platform will leverage AI…